DATE: September 6, 2017
TIME: 9:00AM PST, 12:00PM ET
The era of using extracellular vesicles (EVs) and exosomes for regenerative medicine applications in the clinic is here. We utilize a unique cardiosphere-derived stem-like cell culturing process to manufacture their secreted EVs present in the conditioned medium in large batches for pre-clinical animal studies. This webinar will review the strategies for clinical scale EV manufacturing, characterization of surface phenotypes and RNA cargo, as well as building a pipeline for successful QC of these EVs for use in the clinic.
“The content of the following presentation by Dr. Travis Antes, has not been prepared by, interpreted by or reviewed by Miltenyi Biotec Inc. The views and opinions expressed in the following presentation are solely those of the investigator. All Miltenyi Biotec Inc.’s products discussed herein are for Research Use Only unless otherwise specified.”